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The dioxin receptor (AhR) modulates cell plasticity and migration, although the signaling involved remains unknown.
Here, we report a mechanism that integrates AhR into these cytoskeleton-related functions. Immortalized and mouse
embryonic fibroblasts lacking AhR (AhR/) had increased cell area due to spread cytoplasms that reverted to wild-type
morphology upon AhR re-expression. The AhR-null phenotype included increased F-actin stress fibers, depolarized focal
adhesions, and enhanced spreading and adhesion. The cytoskeleton alterations of AhR/ cells were due to down-
regulation of constitutive Vav3 expression, a guanosine diphosphate/guanosine triphosphate exchange factor for Rho/Rac
GTPases and a novel transcriptional target of AhR. AhR was recruited to the vav3 promoter and maintained constitutive
mRNA expression in a ligand-independent manner. Consistently, AhR/ fibroblasts had reduced Rac1 activity and
increased activation of the RhoA/Rho kinase (Rock) pathway. Pharmacological inhibition of Rac1 shifted AhR/
fibroblasts to the null phenotype, whereas Rock inhibition changed AhR-null cells to the AhR/ morphology. Knock-
down of vav3 transcripts by small interfering RNA induced cytoskeleton defects and changes in adhesion and spreading
mimicking those of AhR-null cells. Moreover, vav3/ MEFs, as AhR/ mouse embryonic fibroblasts, had increased
cell area and enhanced stress fibers. By modulating Vav3-dependent signaling, AhR could regulate cell shape, adhesion,
and migration under physiological conditions and, perhaps, in certain pathological states.
INTRODUCTION
A rapidly increasing number of studies consistently recog-
nize that the aryl hydrocarbon (dioxin) receptor (AhR)
serves a physiological function in the cell. AhR has been best
characterized by its ability to mediate the toxic and carcino-
genic effects of environmental toxicants such as 2,3,7,8 tet-
rachlorodibenzo-p-dioxin (TCDD) (Shimizu et al., 2000; Safe,
2001; Marlowe and Puga, 2005). The mechanism of regula-
tion of AhR during this xenobiotic-dependent process is
relatively well known. Under basal conditions, AhR remains
sequestered in the cytosol in a heteromolecular complex
containing Hsp90, XAP2, p23, and, possibly, additional pro-
teins. On binding to TCDD or other ligands, AhR moves to
the nucleus where it interacts with the aryl hydrocarbon
receptor nuclear translocator and with a partially character-
ized set of coactivators and/or corepressors. These protein
complexes regulate the expression of genes having xenobi-
otic responsive elements (XREs) in their promoters (Whit-
lock, 1999; Barouki et al., 2007; Furness et al., 2007). As
expected, many of the AhR target genes code for xenobiotic-
metabolizing enzymes (Hankinson, 1995; Nebert et al., 2004).
However, it is now known that AhR regulates other gene
subsets with roles not directly linked to xenobiotic responses
(Kolluri et al., 2001; Matikainen et al., 2001; Ogi et al., 2001;
Santiago-Josefat et al., 2004; Chang et al., 2007; Frericks et al.,
2007). The expanding array of AhR target genes, together
with increasing evidence of AhR-regulated physiological
functions in different animal models (Fernandez-Salguero
et al., 1995; Schmidt et al., 1996; Mimura et al., 1997; Barouki
et al., 2007; Furness et al., 2007; McMillan and Bradfield,
2007), has fostered research aimed at defining new signaling
pathways requiring AhR activity.
Several reports have implicated AhR in the regulation of
cell morphology and migration in mammals and in Caeno-
rhabditis elegans (Qin and Powell-Coffman, 2004; Barouki
et al., 2007), although the mechanisms involved remain
rather obscure. Recent data have shown that the effects of
AhR on the shape and motility of MCF-7 breast cancer cells
are mediated via the c-Jun N-terminal kinase (Diry et al.,
2006), a downstream element of the Rac1 pathway (Bustelo
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et al., 2007). We have also recently shown that immortalized
mouse fibroblasts lacking AhR expression (T-FGM AhR/)
display a flattened morphology, increased stress fibers, and
impaired migration (Mulero-Navarro et al., 2005). Moreover,
T-FGM AhR/ cells had lower focal adhesion kinase phos-
phorylation and decreased Rac1, phosphatidylinositol 3-ki-
nase, and extracellular signal-regulated kinase activities
(Mulero-Navarro et al., 2005).
Cell morphology is the result of complex signaling path-
ways that act in concert to regulate F-actin dynamics and the
turnover of cell–cell and cell–substratum interactions (Mitra
et al., 2005). The strength and extent of cell–substratum
interactions significantly determines cell migration and can
be highly relevant in processes requiring major changes in
plasticity such as the epithelial-to-mesenchymal transition
(EMT) (Li et al., 2005). Many proteins coordinately interact
next to the plasma membrane to regulate cell adhesion and
migration. Rho/Rac GTPases such as RhoA, Rac1, and
Cdc42 are relevant players in this process (Clark et al., 1998;
Nobes and Hall, 1999). Thus, it has been shown that RhoA
regulates the formation of F-actin stress fibers and focal
adhesions (Ridley and Hall, 1992; Chen et al., 2002), that
Rac1 promotes the formation of lamellipodia and membrane
ruffles (Ridley et al., 1992; Nobes and Hall, 1999), and that
Cdc42 induced de formation of filopodia (Fukata et al., 2003;
Disanza et al., 2006). To ensure coordinated cytoskeleton
changes, there are multiple cross-talks between RhoA, Rac1,
and other GTPases. For example, it is known that Rac1
stimulation leads to the down-modulation of RhoA activity
and, as a consequence, to the reduction in stress fibers and
focal adhesions in certain cell types (Rottner et al., 1999;
Sander et al., 1999). As most Ras family members, Rho/Rac
proteins have to cycle between an inactive (guanosine diphos-
phate [GDP]-bound) and an active (guanosine triphosphate
[GTP]-bound) states. This cycling is modulated by different
regulators. GDP/GTP exchange factors (GEFs) catalyze the
exchange of GDP by GTP on the GTPases, thus favoring the
rapid transition of these GTPases to their activated state dur-
ing cell signaling. Instead, GTPase-activating proteins
(GAPs) enhance the intrinsic GTPase activity of Rho/Rac
proteins, a process that is essential for the hydrolysis of the
bound GTP and therefore for the transition from the active
to the inactive state at the end of the stimulation cycle.
Rho/Rac proteins are also regulated by other processes,
such as cytosolic sequestration (via GDP dissociation inhib-
itor proteins), ubiquitin-mediated degradation, gene expres-
sion, and phosphorylation (Bustelo et al., 2007). When in the
active state, these proteins bind to effector molecules that
modulate many different biological processes such as cy-
toskeleton changes, gene transcription, vesicle trafficking,
and cell proliferation (Bustelo et al., 2007).
To shed further light in the mechanism by which AhR
mediates these cytoskeleton-related events, we have studied
the effect of AhR gene deficiency in cell shape, adhesion, and
F-actin structures of both immortalized and primary fibro-
blasts. Furthermore, the use of microarray- and signaling-
based strategies has allowed us to pinpoint the connection of
AhR with the vav3 proto-oncogene product, a phosphoryla-
tion-dependent exchange factor for Rho/Rac GTPases.
MATERIALS AND METHODS
Cell Culture
The AhR/ cells used in this study were obtained from AhR-null mice that
were generated by gene knockout as reported previously (Fernandez-Salguero
et al., 1995). Immortalized T-FGM AhR/ and T-FGM AhR/ mouse fibro-
blasts were produced and characterized as described previously (Mulero-
Navarro et al., 2005). T-FGM fibroblasts were grown in DMEM/F-12 medium
containing 10% fetal bovine serum (FBS), 2 mM l-glutamine, 50 g/ml
gentamicin, and 11 mM d-glucose. Primary AhR/ and AhR/ MEF cells
were isolated from 14.5 dpc mouse embryos as indicated (Santiago-Josefat et
al., 2001). Vav3-null and wild-type mice were produced as reported previ-
ously (Sauzeau et al., 2006) and used to isolate primary mouse embryonic
fibroblast (MEF) cells. MEFs were cultured in DMEM supplemented with 10%
FBS, 2 mM l-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin.
Culturing conditions were 37°C and 5% CO2 atmosphere. To induce actin
stress fibers and to analyze changes in morphology, cells were maintained for
12 h in the absence of fetal bovine serum before experimentation.
Antibodies and Reagents
Antibody to paxillin was from BD Biosciences Transduction Laboratories
(Lexington, KY). Anti-vinculin and anti--actin were from Sigma-Aldrich (St.
Louis, MO). Anti-RhoA and anti-Rac1 were purchased from Cell Signaling
Technology (Beverly, MA). Anti-Net1 was obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA). Rhodamine-labeled phalloidin was from Invitrogen
(Carlsbad, CA). Taq DNA polymerase was from Ecogen (Barcelona, Spain).
SuperScript II reverse transcriptase was purchased from Invitrogen. SYBR
Green I was obtained from Invitrogen and QTaq DNA Polymerase mix from
BD Biosciences (San Jose, CA). NSC23766 and Y27632 were obtained from
Calbiochem (San Diego, CA). The expression construct for the constitutively
active AhR (CA-AhR) was a generous gift from Dr. Fujii-Kuriyama (Univer-
sity of Tsukuba, Japan), and it was produced from the wild-type AhR by
deleting the minimal PAS-B motif and by ligating the resulting construct to
the green fluorescent protein (EGFP) (Ito et al., 2004).
SDS-Polyacrylamide Gel Electrophoresis (PAGE)
and Western Immunoblotting
SDS-PAGE and Western blotting were performed using total cell extracts, as
described previously (Santiago-Josefat et al., 2004; Mulero-Navarro et al.,
2005).
Measurement of Cell Area, Immunocytochemistry,
and Rhodamine-Phalloidin Staining
Cell area and the minor/major axis ratio were measured in AhR/ and
AhR/ T-FGM cells and MEFs by blinded analysis in different random fields
for each cell culture. Cellular contour and axis were determined using the
ImageJ software (National Institutes of Health, Bethesda, MD). Significance of
the data was determined as indicated below (see Statistical Analyses). Fluo-
rescence-activated cell cytometry (FACS) was used to determine that T-FGM
AhR/ and T-FGM AhR/ had similar cell volume. For immunocyto-
chemistry, cultures were fixed for 20 min at room temperature in 4% para-
formaldehyde (Polysciences, Warrington, PA). Vinculin and paxillin immu-
nostaining was used to locate focal adhesions in T-FGM cells and MEFs as
reported previously (Santiago-Josefat et al., 2004). To label actin stress fibers,
T-FGM fibroblasts and MEF cells were also stained with rhodamin-phalloidin
(Invitrogen) as indicated (Mulero-Navarro et al., 2005). Fluorescence micros-
copy images were taken using an Axioplan epifluorescence microscope (Carl
Zeiss, Jena, Germany) equipped with Plan-Neufluoar lenses with magnifica-
tions of 20 (0.50 aperture) and 40 (0.75 aperture). Pictures were also taken
using a Plan Apochromat 63 lens (1.40 aperture). Fluorochromes used were
Alexa 488, rhodamine, EGFP, and enhanced yellow fluorescent protein
(EYFP). Images were captured with a CoolSNAP camera (RS Photometrics,
Tucson, AZ) and analyzed using the RS software.
Expression Constructs, Transient Transfections, and RNA
Interference
To generate a vector encoding the AhR-EYFP fusion protein, the full-length AhR
cDNA was cloned into the pEYFP vector as indicated previously (Santiago-
Josefat et al., 2001). To generate a mammalian expression vector for CA-AhR-
EYFP, a modified AhR cDNA encoding a constitutively active version of the
receptor was amplified by polymerase chain reaction (PCR) from pEFBOS-
mAhR-CA and cloned into pEYFP by using previously described protocols
(Santiago-Josefat et al., 2001). Transient transfections were performed in T-FGM
by using the Lipofectamine Plus reagent (Invitrogen) and 1 g of AhR-EYFP,
CA-AhR-EYFP, or Vav3-EGFP expression vectors (Movilla and Bustelo, 1999).
Protein expression was maintained for 24 h, and cultures were analyzed by
fluorescence microscopy as indicated below. vav3 siRNA experiments were
done in T-FGM cells by transient transfection of either 20 or 100 nM of
commercially available siGenome on-Target plus Smart pool (Dharmacon
RNA Technologies, Lafayette, CO). Negative control experiments were also
performed in parallel by transient transfection of unspecific scramble siRNAs
(Dharmacon RNA Technologies).
Reverse Transcription and Real-Time PCR
Total RNA was isolated from T-FGM fibroblasts and MEF cultures by using
the RNeasy kit (QIAGEN, Hilden, Germany). Reverse transcription was per-
formed using random hexamers priming and SuperScript II transcriptase as
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indicated previosly (Gomez-Duran et al., 2006). Real-time PCR was performed
to quantify the expression levels of the vav3 and Cyp1a1 mRNAs. Primers for
vav3 were 5-GGAGTGGAGTCAGCCATCTC-3 (forward) and 5-ATTG-
GAACGACCAGCAAATC-3 (reverse). For Cyp1a1 were 5-ACAGACAGC-
CTCATTGAGCA-3 (forward) and 5-GGCTCCACGAGATAGCAGTT-3 (re-
verse). We used the expression of the -actin mRNA as normalization control.
This cDNA was amplified using the oligonucleotides 5-GGTCAGAAG-
GACTCCTATGTGG-3 (forward) and 5-TCCCTCTCAGCTGTGGTGGT-3
(reverse). Reactions were done using SYBR Green I/QTaq DNA Polymerase
Mix (BD Biosciences) on an iCycler equipment (Bio-Rad, Hercules, CA), as
described previously (Gomez-Duran et al., 2006).
Cloning of the vav3 Promoter, Reporter Gene Analyses,
and Chromatin Immunoprecipitation
The mouse vav3 promoter was cloned from the genomic sequence included in the
WI1-2862P14 phosmid vector (Wellcome Trust Sanger Institute, Cambridge,
United Kingdom). Briefly, the WI1-2862P14 clone was digested with BglII and
a 3574-base pair fragment containing the vav3 promoter cloned into the
pGL2-Basic vector. The resulting clone was then digested with BglII  BstEII
and a 2005-base pair fragment isolated and made blunt ended with Klenow
DNA polymerase. The 2005-base pair fragment was finally ligated into the
SmaI-digested pGL2-Basic vector. The vav3 promoter sequence was analyzed
for potential XRE binding sites by using the consensus element 5-GCGTG-3.
Correct orientation of the vav3 promoter was confirmed by digestion with a
panel of restriction endonucleases. Luciferase reporter gene assays were done
as indicated previously (Roman et al., 2008) by using the dual-glow luciferase
kit (Promega, Madison, WI). The pRLTK vector was used as normalization
control. Firefly and Renilla luciferase activities were determined in a microtiter
plate luminometer MLX (Dynex Technologies, Chantilly, VA). Chromatin
immunoprecipitation (ChIP) to analyze AhR binding to the vav3 promoter
was performed essentially as described previously (Mulero-Navarro et al.,
2006; Roman et al., 2008). Oligonucleotides used for PCR were as follows:
XRE1 forward 5-TCATCCGAGGGTTCACG-3 and reverse 5-GCACTG-
GCTTCCGACTG-3; XRE2 forward 5-AACCTACTTCTTTCCCTCTAC-3
and reverse 5-GGTCCATCCTCAGCCCCTTCC-3; XRE3-4 forward 5-TC-
CTTAGGCTGATTTATTATTGTT-3 and reverse 5-GCTGCTGCTGTTTCAT-
TAGAT-3.
Site-directed Mutagenesis
The XRE1 site in the proximal vav3 promoter was inactivated by site-directed
mutagenesis changing the consensus sequence for AhR binding 5 CACGC 3
to 5 CAGGA 3 by PCR (Gomez-Duran et al., 2008a) (mutated bases under-
lined). Briefly, the pGL2-Vav3 full-length construct was partially digested
with BglI and the linealized DNA further cut with PstI. This fragment was
amplified by PCR using the oligonucleotides forward 5-CCAGCCAGGGCG-
GCGGGCAGGATCCCACCCG 3 and reverse 5 CCGGCCGCCGCTGCAG-
CAGCGAGTGCC 3. Amplification was carried out for 30 cycles in 50-l
reaction mixture containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM each dNTP, 0.5 M each primer, and 2.5 U of Taq polymerase.
Cycling conditions were as follows: denaturation at 94°C for 1 min, annealing
at 60°C for 1 min, and extension at 72°C for 1 min. This PCR fragment was
then digested with BglI and PstI and cloned into the pGL2-Basic vector cut
previously with the same restriction endonucleases. The resulting reporter
construct (pGL2-Vav3-mutXRE1) was transiently transfected into Hepa 1c1c7
and c2 hepatoma cell lines as described above.
Cell Adhesion and Cell Detachment Assays
Cell adhesion was performed on plastic or fibronectin-coated culture dishes.
Twelve-well plates were coated with 0.04, 0.2, 0.7, 1, 4, or 10 g/ml fibronec-
tin. After washing with phosphate-buffered saline (PBS) and culture medium,
T-FGM cells and MEFs were seeded at 3  105 cells/well. After an incubation
of 15 min (T-FGM cells) or 1 h (MEFs), cells were washed in PBS and fixed
overnight at 4°C in 3.7% paraformaldehyde. Cultures were then stained for 15
min with crystal violet (20% methanol solution). After washing and drying,
attached and expanded cells were counted de visu by using light microscopy.
Cell adhesion on plastic was done as above using untreated culture plates.
Cell detachment experiments were also done on plastic using cultures seeded
at the same cell density. After treatment for the indicated periods with a
solution containing 4 mM EGTA and 1 mM MgCl2, cultures were fixed in
ice-cold methanol and stained with 4,6-diamidino-2-phenylindole (DAPI).
Cells that remained attached were counted using the ImageJ software.
RhoA and Rac1 Activation Assays
Pull-down assays with a glutathione transferase (GST) fusion protein con-
taining the RhoA binding domain of rhotekin (rhotekin-GST) or the Rac1
binding domain of PAK-CRIB (PAK-CRIB-GST) were performed essentially
as described previously (Mulero-Navarro et al., 2005). Samples were analyzed
for activated and total RhoA and Rac1 by Western immunoblotting using
specific antibodies.
Microarray Experiments
Two-color cDNA microarrays containing probes for 15,000 mouse genes were
used. Total RNA isolation, labeling, hybridization, normalization, and differ-
ential expression analyses were made as described previously (Martinez-
Delgado et al., 2004).
Statistical Analyses
Data are shown as mean  SEM. Statistical comparison between experimental
conditions was done using GraphPad Prism 4.0 software (GraphPad Soft-
ware, San Diego, CA). One-way analysis of variance followed by Dunn’s test
was applied. For the analyses of cell area and minor/major axis ratio, the
Mann–Whitney nonparametric median statistical analysis was used.
RESULTS
Dioxin Receptor Deficiency Induces Changes in
Cytoskeleton-related Processes in Both Immortalized
and Primary Fibroblasts
We have shown previously that immortalized mouse fibro-
blasts lacking AhR expression (T-FGM AhR/ cells) had
impaired migration rates (Mulero-Navarro et al., 2005). To
further characterize the influence of AhR deficiency in this
biological process, we decided to study in detail the changes
in shape and adhesion of those cells. In addition, and to
avoid secondary effects derived from the immortalization
process, we also conducted these experiments with primary
embryonic fibroblasts (MEFs) derived from AhR/ or
AhR/mice. We observed that, irrespective of the cell type
used, AhR deficiency always correlated with the generation
of cells with enlarged cell area and reduced polarity (Figure
1A). Quantification and statistical comparisons of the mi-
nor/major axis ratio and cell areas corroborated these de
visu observations (Figure 1B). However, the increase in cell
area of AhR/ cells with respect to AhR/ fibroblasts
was not the consequence of higher cell volumes as deter-
mined by FACS analyses (data not shown). Transfection of
AhR-deficient cells with mammalian expression vectors en-
coding yellow fluorescent proteins (YFPs) fused to either
wild-type or constitutively active (lacking the minimal
PAS-B domain) versions of AhR restored the typical shape
and size of the cells (Figure 2, A and B; and Supplemental
Figure S1), confirming that these differences in cell morphol-
ogy were a direct consequence of the loss of AhR expression.
YFP alone did not alter cell shape or size of T-FGM AhR/
or T-FGM AhR/ fibroblasts, further excluding an unspe-
cific effect (Supplemental Figure S2).
To analyze the cytoskeleton in AhR-deficient fibroblasts,
we next stained T-FGM cells and MEFs of the indicated
genotypes with antibodies to paxillin and rhodamine-la-
beled phalloidin to monitor the status of focal adhesions and
the F-actin cytoskeleton in the presence or absence of AhR
expression, respectively. Anti-paxillin immunofluorescence
experiments indicated that the AhR deficiency was associ-
ated with an increase in focal adhesions (Figure 3, A and B,
a and b) and stress fibers (Figure 3, A and B, c and d) both
in T-FGM cells and MEFs. Unlike AhR-positive cells, the
focal adhesions present in AhR-deficient cells were usually
detected around all the cell perimeter rather than been lim-
ited and polarized to areas of membrane protrusions (Figure
3, A and B, a and b). The difference in focal adhesions among
AhR/ and AhR/ cells could be also influenced by
altered expression of focal adhesion (FA)-localized proteins.
Although paxillin expression was similar in AhR/ and
AhR/ T-FGM cells and MEFs, vinculin levels seemed
moderately elevated in T-FGM and MEF AhR/ fibro-
blasts (Supplemental Figure S3). Considering that vinculin
stabilizes FAs and thereby decreases cell migration (Ziegler
et al., 2006), the contribution of this protein to both increased
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FA content and lower migration of T-FGM and MEF
AhR/ fibroblast (Mulero-Navarro et al., 2005; Gomez-
Duran et al., 2009) deserves further consideration.
The functional relevance of AhR in cytoskeleton-related
events was further analyzed by cell spreading and detach-
ment experiments. When plated on fibronectin (FN)-coated
dishes, T-FGM AhR/ cells displayed higher spreading
rates than their wild-type counterparts (Figure 4, A and B,
left). However, these differences became less acute when
these experiments were repeated with coverslips coated
with higher FN concentrations (i.e., 10 g/ml; Figure 4, A
and B, left). Similar results where observed in AhR/
MEFs, although in this case the difference in spreading with
respect to wild-type cells was less pronounced (Figure 4, A
and B, right). The lower spreading rates of AhR/ T-FGM
cells and MEFs was not due to initial defects in substrate
attachment, because total cell counts indicate equal numbers
of attached cells to the dishes regardless of the genotype
used (Figure 4C). The differences in spreading between
AhR/ and AhR/ fibroblasts became even more prom-
inent when the plating step was performed on a plastic
substratum. Thus, whereas T-FGM AhR/ cells showed
negligible spreading on plastic after 60 min of being plated,
50% of the T-FGM AhR/ cells efficiently spread under
identical conditions (Figure 5, A and B, left). Likewise,
AhR/ MEFs displayed much higher spreading rates com-
pared with wild-type MEFs (Figure 5, A and B, right). These
differences in spreading behavior were detected until at least
4 h after plating (Figure 5B, right). Additional controls indi-
cated again that these differences were not due to initial
defects in cell attachment to the plates (Figure 5C).
To further verify the implication of AhR in cell–substra-
tum interactions, we resorted to measuring their kinetics of
detachment upon Ca2 chelation by EGTA treatment (see
Materials and Methods). As shown in Figure 6A, the kinetic of
EGTA-dependent detachment was much slower in T-FGM
AhR/ cells than in their wild-type counterparts. Similar
results were obtained when AhR/ and AhR/ MEFs
were compared, although, similarly to the cell spreading
experiments, the differences with respect to wild-type cells
were less pronounced than in the case of the immortalized
T-FGM cell line (Figure 6B). Together, these data strongly
support a role for AhR in the regulation of cell shape,
cytoskeleton organization, and adhesion. These observa-
tions are also in good agreement with our previous results
indicating that T-FGM AhR/ fibroblasts show lower mi-
gration activity (Mulero-Navarro et al., 2005).
Figure 1. Dioxin receptor expression modulates cell morphology.
(A) Immortalized T-FGM cells and MEFs from AhR/ and
AhR/ mice were plated at the same cell density for each cell type
and starved in the absence of serum for 12 h. After fixation, cultures
were stained with rhodamine-phalloidin and the cellular contours
defined using the ImageJ software. (B) Cell area was measured for
each genotype and cell type, and data represented as median 
SEM (nonparametric Mann–Whitney U test). Minor/major axis ra-
tios were also measured and data analyzed as indicated. At least 15
cells were analyzed for each experimental condition, and the exper-
iments were done in at least two different cultures. The p values for
statistical comparison between genotypes are indicated. The calibra-
tion bar corresponds to 20 m. A.U., arbitrary units.
Figure 2. AhR re-expression changes the AhR-null to the wild-
type phenotype. (A) T-FGM AhR/ cells were plated and trans-
fected with wild-type AhR-EYFP (WT AhR) or constitutively active
AhR-EYFP (CA-AhR) expression constructs. Protein expression was
allowed for 24 h under fetal bovine serum deprivation. Cells were
then stained with rhodamine-phalloidin and analyzed by fluores-
cence microscopy. The ImageJ software was used to measure YFP-
labeled cells in each experimental condition. Arrowheads indicate
cells expressing the ectopic proteins. (B) Cell area and minor/major
axis ratios were calculated for each experimental condition and data
represented as median  SEM. At least 15 transfected cells were
analyzed for each genotype, and the experiments were done in
triplicate. The p values for statistical significance are indicated. The
calibration bar corresponds to 10 m. A.U., arbitrary units.
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The GTPases Rac1 and RhoA Are Involved in the
AhR-dependent Cytoskeleton Changes
Because cytoskeleton-dependent events such as cell shape
and adhesion are regulated by members of the Rho/Rac
GTPase subfamily (Nobes and Hall, 1999; Fukata et al., 2003;
Bustelo et al., 2007), we next explored whether variations in
the expression and/or activity of these GTPases could be the
cause of the phenotype detected in our fibroblast cells. Initial
experiments indicated that the expression of Rac1, RhoA,
and Cdc42 did not change at the mRNA or protein level
(Figure 7A; data not shown), suggesting that AhR does not
affect the expression of these important cytoskeleton regu-
lators. However, pull-down assays using a PAK-CRIB-GST
fusion protein revealed that T-FGM AhR/ cells had re-
duced levels of activated GTP-Rac1 compared with wild-
type T-FGM fibroblasts (Figure 7A, left). Because it has been
reported that Rac1 inhibits RhoA activity in a number of cell
systems (Rottner et al., 1999; Sander et al., 1999), we also
evaluated whether the increase in stress fiber formation and
the reduction in Rac1 activity detected in T-FGM AhR/
cells could be due to increased activity of the RhoA path-
way. To this end, we analyzed the activation status of RhoA
by using pull-down assays with a Rhotekin-GST fusion pro-
tein. These experiments showed that T-FGM AhR/ did
have higher levels of GTP-bound RhoA than the wild-type
cells (Figure 7A, right), indicating that the former cell line
has higher levels of RhoA activity than the latter one.
To verify whether the activity of the Rac1 and RhoA
signaling pathways was altered, we treated T-FGM AhR/
and T-FGM AhR/ cells with NSC23766, a drug that
blocks the interaction of Rac1 with upstream GDP/GTP
exchange factors and, thereby, inhibits its activation in vivo
(Gao et al., 2004). NSC23766 efficiently inhibited Rac1 acti-
vation in T-FGM AhR/ cells (see Figure 10C, bottom) and,
interestingly, we observed that the addition of this com-
pound to T-FGM AhR/ cells induced a morphologically
phenotype similar to that found in T-FGM AhR/ cells,
whereas it did not significantly affect the phenotype of AhR-
Figure 3. AhR-null cells have unpolarized focal adhesions and
increased actin stress fibers. (A) T-FGM AhR/ and T-FGM
AhR/ cells were plated, starved for 12 h by fetal bovine serum
deprivation and analyzed for focal adhesions content and distribu-
tion using anti-paxillin immunostaining and an Alexa 488-labeled
secondary antibody (a and b) or for F-actin by using rhodamine-
phalloidin staining (c and d). (B) The same experiments were per-
formed in MEF cultures for focal adhesions (a and b) or actin stress
fibers (c and d). The experiment was repeated in at least four
different cultures of each cell type and genotype with same results.
Bar, 5 m. Arrowheads mark focal adhesions in a and b or actin
stress fibers in c and d.
Figure 4. The absence of AhR increases cell spreading on fibronec-
tin. (A) T-FGM cells and MEF of the indicated genotypes were
cultured on dishes previously coated with increasing concentrations
of FN (0.04, 0.2, 4.0, or 10 g/ml). Representative results obtained at
0.04 and 10 g/ml are shown for each genotype and cell type. (B)
Cell spreading was quantified at 15 min (T-FGM cells) or 60 min
(MEFs) by cell counting after crystal violet staining. Cytoplasmic
extensions indicative of spreading was determined by blinded anal-
ysis. Percentages of spread cells were referred to the total number of
cells within the same microscopy field. Between 250 and 300 T-FGM
cells or 100 MEFs were counted in six independent fields for each
experimental condition. The p values for statistical comparison
between genotypes are indicated. (C) The total number of cells
attached to the plates was counted for each FN concentration. Data
are shown as mean  SEM from cells counted in at least two
different cultures of each genotype and cell type.
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null cells (Figure 7B, compare a and b). Those changes seen
in T-FGM AhR/ cells included the prototypical increase
in both the cell area and stress fiber formation, a result that
suggest that the phenotype induced by AhR deficiency may
be mediated by decreased signals from the Rac1 pathway.
Next, we treated AhR/ and AhR/ T-FGM cells with
Y27632, a specific inhibitor of the serine/threonine kinase
Rock (Uehata et al., 1997). This kinase is a downstream ele-
ment of RhoA that mediates the formation of stress fibers and
the actomyosin ring (Riento and Ridley, 2003; Shimokawa and
Rashid, 2007). Y27632 induced the rapid disassembly of the
stress fibers and, in addition, the acquisition of a T-FGM
AhR/-like morphology in the AhR-null cells (Figure 7C,
compare a and c). These results indicate that the AhR-
dependent changes in cell morphology in these fibroblast
cell lines rely, at least in part, in the differential engagement
of the GTPases Rac1 and RhoA.
AhR Regulates the Constitutive Transcription of Vav3,
which Is a Major Intermediate Modulating the AhR-
dependent Phenotype
Because the expression levels of Rac1 and RhoA did not
change depending on the AhR status of the cell (see above),
we speculated that the variations in the activities of their
signal transduction pathways could be mediated by alter-
ations in upstream molecules (GEFs), negative regulators
(i.e., GAPs), and/or downstream elements. Given the large
number of putative AhR targets, we decided to conduct
microarray experiments to obtain a global, genome-wide
view of the transcriptomal differences present in T-FGM
AhR/ and T-FGM AhR/ cells. The functional annota-
tion of the transcriptomal changes indicated that the AhR
deficiency induced the down-modulation of a subset of
RhoA (Net1) (Alberts and Treisman, 1998), Rac1 (Sos1, Vav3,
and Abr) (Chuang et al., 1995; Nimnual et al., 1998; Bustelo,
2000), and Ras (Sos1) (Boguski and McCormick, 1993) GEFs
as well as of two Rab family members (Rab1 and Rab9)
(Figure 8A). In addition, it up-regulated the expression of two
Rho/Rac GAPs (ArhGAP18 and ArhGAP20) and the Rab8
GTPase (Figure 8A). Two main regulators of RhoA and Rac1
GTPases that seemed markedly repressed in T-FGM AhR/
cells were Vav3 and Net1 (Burridge and Wennerberg, 2004).
Given previous results indicating the importance of Vav3 in
cytoskeleton organization (Movilla and Bustelo, 1999; Horn-
stein et al., 2004; Couceiro et al., 2005) and its marked down-
regulation in T-FGM AhR/ cells, we decided to verify
whether the modulation of this exchange factor by AhR
could be a component of the cytoskeleton-related effects of
this transcriptional factor. To this end, we first investigated
whether the vav3 proto-oncogene was indeed a potential
Figure 5. The absence of AhR increases cell spreading on plastic.
(A) T-FGM cells and MEFs from AhR/ and AhR/ mice were
cultured on untreated plastic dishes for the indicated times and cells
stained with crystal violet. (B) Cell spreading was quantified for
each experimental condition as indicated in the legend for Figure 4.
The p values for statistical comparison between genotypes are in-
dicated. (C) The variation with time of the total number of attached
cells was also determined for each cell type and genotype. Data are
shown as mean  SEM from cells counted in at least two different
cultures of each genotype and cell type.
Figure 6. AhR expression decreases cell adhe-
sion to the substratum. (A) T-FGM AhR/ and
T-FGM AhR/ cells were seeded at the same
cell density on plastic dishes and then induced
to detach by using treatments with EGTA for
the indicated times. Nuclei were stained with
DAPI, and attached cells counted using the Im-
ageJ software. (B) MEFs of the indicated geno-
types were cultured at the same initial cell den-
sity and processed and analyzed as described in
A. Data are shown as mean  SEM for measure-
ments made in duplicate in at least two inde-
pendent cultures for each genotype and cell
type. The p values for statistical comparison
between genotypes are indicated.
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AhR transcriptional target. Consistent with the microarray
results, we observed that the vav3 transcript was remarkably
decreased in AhR/ T-FGM and MEFs cells, as determined
by quantitative, real-time PCR analysis (Figure 8B, left and
middle). Importantly, unlike other classical AhR targets
such as Cyp1a1 (Figure 8B, right) (Hankinson, 1995; Whit-
lock, 1999; Nebert et al., 2004), the expression of the vav3
mRNA could not be enhanced by the addition of the AhR
ligand TCDD to T-FGM AhR/ cells (Figure 8B, left and
middle). These results indicate that AhR functions as a tran-
scription factor committed to maintain the constitutive expres-
sion of vav3, and suggest a relevant role for the physiological
levels of Vav3 in the regulation of the AhR-dependent pheno-
type. Regarding Net1, we have analyzed protein expression
by Western immunoblotting and found that, although re-
pressed in our cDNA expression arrays, Net1 had similar
protein levels in T-FGM AhR/ and T-FGM AhR/ (Fig-
ure 8C). Even though the regulation of Net1 could deserve
further analysis, based on its similar protein levels in T-FGM
AhR/ and T-FGM AhR/ fibroblasts, we focused our
study on Vav3.
We decided to isolate the mouse vav3 gene promoter and
to further characterize its regulation by AhR. A 2005-base
pair upstream genomic fragment containing the vav3 pro-
moter was cloned that contained four XRE consensus ele-
ments for AhR binding. These were located at 369 (XRE1),
823 (XRE2), 1484 (XRE3), and 1499 (XRE4) with respect
to the translation start codon ATG (Figure 9A, top). We then
analyzed the functionality of this promoter sequence by
luciferase reporter assays using wild-type mouse hepatoma
Hepa 1c1c7 cells and its variant c2 clone (expressing 10%
wild-type levels of AhR). In agreement with an AhR-depen-
dent process, vav3 promoter activity was higher in wild-type
1c1c7 than in AhR-deficient c2 hepatoma cells (Figure 9A,
right). Furthermore, the reexpression of AhR by the pcDNA-
AhR expression vector in c2 cells restored vav3 promoter
activity to values close to those observed in wild-type 1c1c7
cells (Figure 9A, right). To further demonstrate that AhR
contributes to the transcriptional regulation of vav3 expres-
sion, ChIP assays were conducted. AhR binding to the XRE1,
XRE2, and XRE3-4 elements was analyzed by PCR in AhR
immunoprecipitates. The results showed that AhR was re-
cruited to the proximal XRE1 element on the vav3 promoter
(Figure 9B), thus supporting the fact that vav3 is an AhR-
regulated gene in the mouse. Moreover, the XRE1 element is
indeed necessary for vav3 promoter regulation since its in-
activation by site-directed mutagenesis abrogated the ability
of the vav3 promoter to drive luciferase reporter activity in
AhR-expressing wild-type 1c1c7 cells (Figure 9C).
These results prompted us to further analyze the contri-
bution of Vav3 to the AhR-dependent phenotype. We hy-
pothesized that if a reduction in the physiological levels of
Vav3 expression in AhR-deficient cells were involved in
determining their characteristic morphological phenotype,
the knockdown of the vav3 mRNA in wild-type fibroblasts
should induce an AhR-null-like phenotype. To address this
possibility, we transfected vav3-specific small interfering
RNAs (siRNAs) in T-FGM AhR/ cells, and, 72 h later, we
monitored the morphology, polarity, and cytoskeleton
changes in mock- and vav3 siRNA-transfected cells by using
microscopy techniques. As an additional control, we used in
these analyses untranfected T-FGM AhR/ cells. We ini-
tially determined by Western immunoblotting that T-FGM
AhR/ cells expressed lower Vav3 protein levels and that
vav3-specific siRNAs, but not unspecific scramble siRNAs,
consistently reduced Vav3 protein expression to 30% its
basal levels in T-FGM AhR/ cells (p  0.05) (Figure 10A).
Notably, vav3 knockdown induced a shift in the morphology
of T-FGM cells from the wild-type to the AhR-null-like phe-
notype (Figure 10B). This change included the increase in
cell area (Figure 10B, compare a with c and d and e with g
and h), the promotion of stress fiber formation (Figure 10B,
compare a with c and d), increased numbers of focal adhe-
sions that localize around the cell edges (Figure 10B, com-
pare e with g and h), and cell depolarization (Figure 10B,
compare e with g and h). Transfection of unspecific scramble
siRNAs, on the contrary, did not change these phenotypes in
T-FGM AhR/ cells (Figure 10B, b and f). We then ana-
lyzed whether knockdown of Vav3 expression in fact af-
fected its downstream target proteins RhoA and Rac1. Con-
sistent with the role proposed for Vav3 in the regulation of
the Rac1 and RhoA signaling pathways, down-modulation
Figure 7. Rac1 and RhoA contribute to the AhR-dependent control
of cell morphology. (A) Levels of Rac1 (GTP-Rac1) and RhoA (GTP-
RhoA) activation were measured in T-FGM AhR/ and T-FGM
AhR/ cells by pull-down assays by using the PAK-CRIB-GST or
Rhotekin-GST target proteins, respectively. Total cellular levels of
Rac1 and RhoA were also determined by Western blot (W.B.) using
anti-Rac1 and anti-RhoA antibodies. The levels of GTP-RhoA and
GTP-Rac1 were quantified and normalized by total RhoA and Rac1
expression, respectively. Data are shown as mean  SEM from at
least two independent cultures. The p values for statistical compar-
ison between genotypes are indicated. (B) T-FGM AhR/ and
T-FGM AhR/ cells were plated and treated for 6 h with the Rac1
inhibitor NSC23766 (5 M) or (C) with the Rock inhibitor Y27632 (10
M). Cells were then fixed, stained with rhodamine-phalloidin, and
photographed. The experiment was done in three different cultures
with the same results. Bar, 5 m.
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of Vav3 protein levels by vav3 siRNAs had an effect on these
GTPases, and thus RhoA activation was increased, whereas
Rac1 activation was decreased in transfected T-FGM
AhR/ cells (Figure 10C). As indicated above, transfection
of unspecific scramble siRNAs did not affect RhoA or Rac1
activation in T-FGM fibroblasts of either genotype (Figure
10C). We also confirmed that Rac1 has a prominent role in
the phenotypic changes induced by NSC23766 in T-FGM
AhR/ cells (Figure 7B) because this molecule decreased
Rac1 activity in our pull-down assays (Figure 10C, bottom
right). These results support that AhR, through the control
of constitutive Vav3 expression and by modulating the ac-
tivation of its downstream target proteins RhoA and Rac1,
has a relevant role in determining fibroblast cell phenotype.
In addition, because Vav3 can be regulated by phosphory-
lation (Bustelo, 2002; Llorca et al., 2005), we also analyzed
whether T-FGM AhR/ cells had a lower phosphorylation
potential that could contribute to a reduction in Vav3 sig-
naling. T-FGM AhR/ and T-FGM AhR/ cells were
transfected with a myc-tagged Vav3 expression construct
and the levels of pVav3 determined by Western immuno-
blotting in myc immunoprecipitates. Both cell lines had a
similar potential to phosphorylate Vav3 (Supplemental Fig-
ure S4), further supporting that decreased Vav3 protein
expression is a major determinant in the AhR-dependent
phenotype. We also performed overexpression experiments
in which T-FGM AhR/ and T-FGM AhR/ fibroblasts
were transfected with the wild type or with a constitutively
Figure 8. AhR regulates constitutive vav3
mRNA expression. (A) Total RNA purified
from T-FGM AhR/ and T-FGM AhR/
cells was analyzed by microarrays as indi-
cated in Materials and Methods. Genes above
and below the horizontal dotted line are over-
expressed or repressed, respectively. (B) vav3
mRNA expression was determined by real-
time PCR in T-FGM cells and MEFs of the
indicated genotypes under basal conditions or
after a 24-h-long treatment of TCDD (10 nM).
As positive control for TCDD-dependent AhR
activation, mRNA levels of the target gene
Cyp1a1 were determined in parallel. Gene ex-
pression was normalized among the different
experimental conditions using as comparative
control the expression of the -actin gene. (C)
Net1 protein expression was analyzed in
T-FGM AhR/ and T-FGM AhR/ by
Western immunoblotting using 15 g total
protein and a specific antibody. The expres-
sion of -actin was used as loading control.
Data are shown as mean  SEM from tripli-
cate measurements. The experiments were
done in two different cultures of each geno-
type and cell line. The p values for statistical
comparison between genotypes and between
untreated and TCDD-treated AhR/ T-FGM cells are indicated.
Figure 9. vav3 is a new transcriptional target of
the AhR. (A) A 2005-base pair fragment of up-
stream genomic sequence containing the vav3
mouse promoter was cloned from the WI1-
2862P14 phosmid into the pGL2-Basic vector.
The resulting construct was transfected in wild-
type Hepa 1c1c7 cells or in the AhR-deficient c2
line (expressing 10% wild-type levels of AhR)
and firefly luciferase activity measured and nor-
malized by Renilla luciferase activity. (B) Four
XRE consensus elements for AhR binding were
located in the vav3 promoter. AhR binding to
these XREs was determined by ChIP in T-FGM
AhR/ and T-FGM AhR/ cells. The loca-
tion of the oligonucleotides used to amplify by
PCR the regions of the vav3 promoter contain-
ing XRE sequences is indicated. Positive con-
trols were performed using the input fractions
whereas negative controls were made in the
absence of antibody. (C) Site-directed mutagen-
esis was used to inactivate the XRE1 site in the
vav3 promoter. The mutated form of the pro-
moter was cloned into the pGL2-Basic vector
and the resulting construct transfected in wild-type Hepa 1c1c7 or in AhR-deficient c2 cells. Mutant vav3 promoter activity was analyzed by
luciferase assays as indicated above.
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active version of Vav3 (1-184 deletion mutant). We found
that Vav3 overexpression produced the same morphological
alteration in T-FGM fibroblasts regardless on their AhR
status (Supplemental Figure S5), suggesting that conditions
Figure 10. The knockdown of the vav3 mRNA phenocopies the cytoskeleton-related changes observed in T-FGM AhR/ cells. (A) Vav3
protein expression was determined in T-FGM AhR/ and T-FGM AhR/ cells by Western blot with an anti-Vav3 antibody. In parallel
experiments, vav3 siRNAs or unspecific scramble RNAs were transfected in T-FGM cells of both genotypes and Vav3 protein expression
determined as described above. The expression of -actin was used as control. Vav3 protein levels were normalized by -Actin for each
experimental condition and the results obtained represented on the right panel. (B) T-FGM AhR/ cells were transfected with vav3 siRNAs
or with unspecific scramble RNAs and, 72 h later, stained with rhodamine-phalloidin (Rho-Pha) to visualize the F-actin cytoskeleton (a–c)
or used in anti-paxillin immunofluorescence experiments to analyze their pattern of focal adhesions (e–g). T-FGM AhR/ cells were also
stained under the same conditions for comparison (d and h). Actin stress fibers and focal adhesions are indicated by arrowheads in c and
d and g and h, respectively. Bar, 5 m. (C) T-FGM AhR/ and T-FGM AhR/ cells were grown and cell extracts prepared and used in
pull-down assays for RhoA and Rac1 by using the rhotekin-GST and the PAK-CRIB-GST fusion proteins as targets, respectively. T-FGM cells
of both genotypes were also transfected with vav siRNAs or with unspecific scramble siRNAs as described above and used in pull-down
assays as described in B. In additional experiments, T-FGM AhR/ and T-FGM AhR/ cells were treated with NSC23766 as indicated in
the legend for Figure 7, and its effect on the levels of Rac1 activation was determined by pull-down assays as described above. Protein levels
for RhoA and Rac1 were also determined by Western blotting (W.B.) in the same cell extracts. Levels of GTP-RhoA and GTP-Rac1 were
normalized by total RhoA and Rac1 protein, and the values are plotted (right). Data are shown as mean  SEM from experiments performed
in two different cultures of each genotype. The p values for statistical comparison between genotypes under the different experimental
conditions are indicated.
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in which Vav3 activity largely exceeds its constitutive cellu-
lar levels, could abolish the physiological control of cell
morphology making the process AhR independent. We used
an additional experimental approach to further support that
overactivation of Vav3 signaling alters cell morphology in-
dependently of AhR. Because Vav3 overactivation should
increase the activity of its downstream client protein Rac1,
transfection of a constitutively active form of Rac1 should
also induce a phenotypic change regardless of AhR expres-
sion. T-FGM AhR/ and T-FGM AhR/ cells were trans-
fected with a wild-type or a constitutively active form of
Rac1 and their effects on cell morphology analyzed (Supple-
mental Figure S6). Transfection of wild-type Rac1 did not
significantly change the basal morphology of T-FGM AhR/
and T-FGM AhR/ cells (Supplemental Figure S6A). How-
ever, the constitutively active version of Rac1 (V12Rac1; del
Pozo et al., 1999) induced a change in cell area and polarity
that was of similar magnitude in both T-FGM cell lines
(Supplemental Figure S6B). Thus, overactivation of Vav3-
dependent signaling overrides the influence of AhR in the
control of fibroblast cell phenotype. Together, these data
support a mechanism in which highly regulated control of
constitutive Vav3 expression by the transcriptional activity
of AhR has an important role in modulating fibroblast shape
and cytoskeleton under physiological conditions.
To investigate whether the reduced Vav3 expression
also participated in the enhanced adhesion properties of
T-FGM AhR/ cells, we measured the effect of the vav3
knockdown in the detachment and spreading properties
of wild-type T-FGM cells. As shown in Figure 11A, the
vav3 knockdown increased the attachment efficiency of T-
FGM AhR/ in the presence of EGTA to values signifi-
cantly higher than those observed in untransfected wild-
type cells. Transfection of unspecific scramble siRNA, on the
contrary, did not affect the attachment efficiency of T-FGM
AhR/ cells (Figure 11A, right). Moreover, vav3 siRNA-
transfected T-FGM AhR/ cells did gain ability to spread
on plastic, reaching values close to those found in T-FGM
AhR/ cells 60 min after plating (Figure 11B). Together,
these data indicate that Vav3 is a bonafide AhR target im-
plicated in the cytoskeleton-dependent effects induced by
this transcriptional factor.
Vav3 Null MEFs Had Increased Cell Area and Enhanced
Actin Stress Fibers Content
To provide even further support to our hypothesis that Vav3
has an important contribution to the AhR-dependent phe-
notype in fibroblast cells, vav3/ MEFs were isolated and
their morphology and ability to generate actin stress fibers
was analyzed. Cell area and minor/mayor axis ratio were
determined as indicated in Figure 1. vav3/ MEFs had a
significant increase in cell area without a change in minor/
mayor axis ratio (Figure 12A), a phenotype closely mimick-
ing that found in AhR/ MEFs (see Figure 1). F-Actin
staining with rhodamine-labeled phalloidin was used to
analyze actin stress fibers content. Loss of Vav3 expression
produced an increase in stress fibers with respect to vav/
MEFs (Figure 1, A and B, b) that resembled the effects
Figure 11. Vav3 down-regulation increases
the spreading and attachment efficiency of T-
FGM AhR/ cells. (A) vav3 siRNAs- or un-
specific scramble siRNAs-transfected T-FGM
AhR/ fibroblasts were used in EGTA-in-
duced detachment experiments. At the indi-
cated times, nuclei were stained and counted as
indicated in Figure 6. The p values for statistical
comparison between vav3 siRNA-transfected
T-FGM AhR/ and untransfected wild-type
cells are indicated. (B) T-FGM AhR/ cells
were transfected with vav3 siRNAs and their
spreading efficiency determined after crystal vi-
olet staining. Between 250 and 300 T-FGM cells
were counted in six independent fields for each
experimental condition. The p values for statistical comparison in the increase of cell spreading with time in T-FGM AhR/ cells are
indicated. Data are shown as mean  SEM from duplicate experiments in two different cultures.
Figure 12. vav3/ MEFs have increased cell area and enhanced
actin stress fibers content. (A) MEF cells were isolated from vav3/
and vav3/ mice and analyzed for cell size and polarity (minor/
major axis ratio) as indicated in the legend for Figure 1. (B) The
F-actin stress fibers were revealed by rhodamin-labeled phalloidin
as indicated in the legend for Figure 3. At least 20 cells were
analyzed for each experimental condition, and the experiments
were done in two different MEF cultures. The p values for statistical
comparison between genotypes are indicated. Bar, 10 m (A) and 5
m (B). A.U., arbitrary units.
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described in AhR-null MEF cells (Figures 3, 7, and 10). The
fact that genetically modified vav3/ MEFs share common
phenotypes regarding cell morphology and actin stress fi-
bers with AhR/ MEFs, strongly support our premise that
Vav3 is a downstream target of AhR and that both proteins
have a role in determining the phenotype of fibroblastic
cells.
DISCUSSION
AhR is a critical intermediate in xenobiotic-induced toxicity
and carcinogenesis (Fernandez-Salguero et al., 1996; Peters
et al., 1999; Shimizu et al., 2000) and many studies have
analyzed its role in cell cycle, differentiation, apoptosis, and
genome integrity (Lahvis et al., 2005; Barouki et al., 2007;
Furness et al., 2007; McMillan and Bradfield, 2007). Despite
these known functions, emerging evidence indicates that
AhR may be also involved in cytoskeleton-related processes.
Thus, it has been shown that cell detachment leads to the
transcriptional activation of AhR in several adherent cells
such as keratinocytes (Sadek and Allen-Hoffmann, 1994a),
hepatoma Hepa I cells (Sadek and Allen-Hoffmann, 1994b),
and C3H10T1/2 fibroblasts (Cho et al., 2004). Moreover, it
has been observed that AhR has a predominantly nuclear
distribution in cells located at the migrating edge in wound
healing experiments (Ikuta and Kawajiri, 2006). It was also
reported that both the ligand-dependent and the constitu-
tive activation of AhR in the immune system leads to en-
hanced migration of CD4CD8 double-negative lympho-
cytes from the thymus (Esser et al., 2004; Temchura et al.,
2005). Finally, a recent work has shown that either dioxin
or a constitutively active form of the AhR induce morpho-
logical changes that affect the F-actin cytoskeleton, cell–
cell interactions, and the motility of breast tumor cells
(Diry et al., 2006). Despite this knowledge, the contribu-
tion of AhR to cell morphology, adhesion, and migration
under physiological, xenobiotic-free conditions, remains
largely unknown.
Consistent with a link between AhR and cytoskeleton-
related processes, we report here that AhR status affects cell
shape, F-actin cytoskeleton, adhesion, and spreading of mu-
rine fibroblasts. A first indication of the mechanism through
which AhR can modulate cell morphology and adhesion
comes from our results with the constitutively active AhR
protein. The expression of constitutively active AhR in
AhR/ fibroblasts rescues the morphological phenotype of
these cells, suggesting that the process requires the tran-
scriptional activity of the receptor. The spread morphology
of AhR/ cells was associated to prominent actin stress
fibers and to increased numbers of focal adhesions with a
depolarized distribution around the cell area. Focal adhe-
sions are major structures for cell–substratum interaction
(Sieg et al., 1999; Schaller, 2001) and, indeed, spreading and
attachment were significantly enhanced in AhR-null with
respect to wild-type cells. These are relevant data that could
help interpreting the lower migration rates observed in
T-FGM AhR/ fibroblasts (Mulero-Navarro et al., 2005) and
MEF AhR/ cells (Carvajal-Gonzalez, unpublished data).
Rac1 and RhoA play crucial roles in cell migration, polar-
ity, adhesion, and cytoskeleton reorganization (Nobes and
Hall, 1999; Bishop and Hall, 2000). The importance of these
GTPases in determining AhR-dependent morphology was
confirmed by two facts: 1) more spread and highly attached
T-FGM AhR/ cells had higher RhoA and lower Rac1
activation than wild-type fibroblasts and 2) the Rac1 inhib-
itor NSC23766 changed the morphology of AhR/ fibro-
blasts to that of AhR/ cells, whereas the RhoA kinase
inhibitor Y27632 did the opposite and transformed AhR-null
cells into the wild-type phenotype. Moreover, these results
are in close agreement with previous data indicating that
Rac1 and RhoA have antagonistic effects in different cell
types (Leeuwen et al., 1997; Sander et al., 1999). Interestingly,
however, protein expression for Rac1 and RhoA was similar
between T-FGM AhR/ and T-FGM AhR/ cells, sug-
gesting that AhR regulated these GTPases at the level of
their activation and/or downstream elements. To find pos-
sible targets, we carried out expression microarrays in T-
FGM AhR/ and T-FGM AhR/ cells and searched for
GTPases and/or GTPase regulators. This analysis indicated
that the phosphorylation-dependent exchange factors Vav3
and Net 1 (Movilla and Bustelo, 1999; Hornstein et al., 2004)
were significantly down-regulated in AhR/ cells. We fo-
cused on Vav3 because Net1 protein levels did not signifi-
cantly differ between T-FGM AhR/ and T-FGM AhR/
cells. Cloning of the murine vav3 promoter revealed that
AhR expression increases vav3 promoter activity and that
AhR is recruited to a proximal XRE element in the vav3
promoter. Interestingly, the high-affinity AhR ligand TCDD
did not increase the AhR-dependent vav3 expression, sug-
gesting not only that AhR is committed to regulate consti-
tutive gene transcription of vav3 but also that the physiolog-
ical levels of Vav3 could be relevant to mediate the effects of
AhR on cell phenotype.
The constitutive transcription of Vav3 has been related to
the reorganization of actin stress fibers and to the formation
of lamellipodia and membrane ruffles (Movilla and Bustelo,
1999; Bustelo, 2000) and, as such, represents a candidate
target gene whose regulation by AhR could modulate cell
morphology, adhesion, and spreading. We hypothesized
that the down-regulation of vav3 mRNA and protein in
fibroblasts could account for the cytoskeleton-dependent
changes observed in AhR-deficient cells. Indeed, siRNA-
based experiments, which down-regulate the physiological
levels of target genes, demonstrated that this exchange fac-
tor represents an important intermediary in the AhR-depen-
dent signaling pathways determining cell morphology.
Thus, we observed that down-regulation of Vav3 in T-FGM
AhR/ cells induced a T-FGM AhR-null-like phenotype
regarding cell shape, cytoskeleton organization, polarity,
adhesion, and spreading that was consistent with the
changes observed in the activation of the Vav3 downstream
GTPases Rac1 and RhoA. The fact that overexpression of the
wild-type or a constitutively active Vav3 or a constitutively
active form of Rac1 changed cell morphology independently
on AhR expression, further support the hypothesis that the
physiological level of Vav3 is a highly regulated parameter
in the AhR-dependent modulation of cellular morphology.
Indeed, vav3/ MEFs mimicked the AhR/ phenotype
with respect to increased cell area and enhanced actin stress
fibers content, strongly indicating not only that Vav3 is a
downstream target of AhR but also that constitutive Vav3
levels are required to maintain fibroblast morphology and
cytoskeleton. Therefore, the AhR-dependent phenotype for
cell morphology, adhesion, and spreading is controlled, at
least in part, by the precise regulation of the physiological
levels of the exchange factor Vav3. This is a relevant exam-
ple of how AhR can modulate physiologically defined cel-
lular properties through the transcriptional regulation of an
endogenous target gene that controls migration-related sig-
naling pathways. Although these data attribute a relevant
role for the transcriptional activity of AhR in determining
cell phenotype, additional, transcription-independent mech-
anisms, cannot yet be excluded. For example, as a cullin 4B
ubiquitin ligase (Ohtake et al., 2007), the liganded AhR could
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regulate the levels of migration-related proteins through the
proteasome by a mechanism similar to that demonstrated
previously for sex steroid receptors (Ohtake et al., 2007).
It is worth noting that our data do not exclude the partic-
ipation of other signaling molecules in the AhR-mediated
cytoskeleton effects in fibroblasts. For example, scaffolding
proteins such as vinculin or other GEFs and GAPs are also
dependent on the presence of AhR, at least in the case of
fibroblasts. It is therefore possible that these additional pro-
teins could cooperate with, or participate in parallel path-
ways, to those already engaged by Vav3. Further work in
this area will address this possibility and unveil the level of
cross-talk and cooperativity between these pathways. Given
the important role of Rho/Rac pathways in pathologies such
as cancer, immunodeficiencies or cardiovascular disease, it
will be also interesting to see whether AhR may contribute
to the regulation of those pathways in the context of these
pathological states.
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